Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06578897 · ClinicalTrials.gov registry record
A Post-Market, Retrospective Study on 3D Metal Tibial and Femoral Cones
A clinical trial of Total Knee Arthroplasty, sponsored by Medacta International.
- Completed
- Registry status
- 118
- Enrollment target
- 1
- Study location
NCT06578897: Completed study of Total Knee Arthroplasty, sponsored by Medacta International.
NCT06578897 is a study of Total Knee Arthroplasty that has completed, run by Medacta International. The registered enrollment target is 118 participants, below the 291-participant average among 29 other Total Knee Arthroplasty trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06578897, a study of Total Knee Arthroplasty, has completed, sponsored by Medacta International.
- COMPLETED
- Registry status
- 118 participants
- Enrollment target
- 1
- Study location
Study Summary
GMK Revision Knee System is part of the Medacta GMK® (Global Medacta Knee) Total Knee System and is indicated when a higher level of varus/valgus constraint is needed. The external shape of the GMK® Revision femoral component is identical to that of GMK® Primary. The GMK® Revision differs from GMK® Primary by three important design features: i. The addition of a box which allows a stem to be inserted into the femoral canal; ii. The addition of screw lugs so that augments can be placed on the distal and posterior resections, and; iii. The box which also allows various levels of constraint to be added to the polyethylene insert. The tibial component offers the ability to place augments. Indications for Use: The GMK® Total Knee System is designed for cemented use in total knee arthroplasty if there is evidence of sufficient sound bone to seat and support the components. This knee replacement system is indicated in the following cases: * Severely painful and/or disabled joint as a result of arthritis, traumatic arthritis, rheumatoid arthritis or polyarthritis * Avascular necrosis of femoral condyle * Post traumatic loss of joint configuration * Primary implantation failure * Ligamentous Instability Tibial augments are to be attached to the tibial baseplate with both the fixing cylinders and bone cement. In case a semi-constrained liner is used, an extension stem must be implanted both on the tibial and on the femoral component. GMK® Revision femoral components are manufactured of Cobalt Chromium Molybdenum (CoCrMo) according to ISO 5832-4:1996, Implants for Surgery- Metallic materials - Part 4: Cobalt-Chromium-Molybdenum Casting Alloy, the same as the GMK® Primary femoral components. They have an asymmetric patellar groove (left and right) with different radii of curvature in coronal plane as well as non-parallel anterior and posterior cuts (wedge shape). The GMK® Revision posterior stabilized femoral components are designed for use without cruciate ligaments whe
Primary Outcome
Oxford Knee Score (OKS) is a 12-item patient-reported PRO specifically designed and developed to assess function and pain after total knee replacement (TKR) surgery (arthroplasty). The overall score for the OKS is acquired by simply summing the scores received for individual questions. This results in a continuous score ranging from 0 (most severe symptoms/problems) to 48 (least severe).
Conditions Studied
Interventions
- DEVICE 3D Metal Tibial and Femoral cones
Study Locations (1)
Illinois
- Northwestern - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2024-02-13 |
| Est. Completion | 2025-02-13 |
What the finished NCT06578897 record still lists
NCT06578897 is an observational study that tracks outcomes without assigning an intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap, below the 291-participant average among 29 other Total Knee Arthroplasty trials with a reported enrollment target (59% lower).
The record links to 1 condition, with Total Knee Arthroplasty appearing as the primary indexed condition, and to 1 intervention - of which 3D Metal Tibial and Femoral cones is the first listed.
NCT06578897 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06578897 about?
NCT06578897 is a clinical study titled "A Post-Market, Retrospective Study on 3D Metal Tibial and Femoral Cones". GMK Revision Knee System is part of the Medacta GMK® (Global Medacta Knee) Total Knee System and is indicated when a higher level of varus/valgus constraint is needed. The external shape of the GMK® Revision femoral component is identical to that of GMK® Primary. The GMK® Revision differs from GMK® ...
What is the current status of trial NCT06578897?
This trial is currently completed. The enrollment target is 118 participants. The study started on 2024-02-13. Estimated completion is 2025-02-13.
What conditions does trial NCT06578897 study?
This clinical trial studies the following conditions: Total Knee Arthroplasty.
What interventions are being tested in trial NCT06578897?
The interventions under investigation include: 3D Metal Tibial and Femoral cones (DEVICE).
Who is sponsoring clinical trial NCT06578897?
This trial is sponsored by Medacta International, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06578897 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Total Knee Arthroplasty
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06578897's enrollment target sits among peer trials
118 14th of 29 higher than 15 of 29 other Total Knee Arthroplasty trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Total Knee Arthroplasty trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Intraoperative VR for Older Patients Undergoing TKA
RECRUITING · NA
-
A Prospective, Randomized Parallel Group Study of the Efficacy of Vancomycin Administered Through Intraarticular Injection Versus Intraosseous Injection Versus Intravenous Infusion in Patients Undergoing Total Knee Arthroplasty
RECRUITING · Phase 4
-
Investigating Patient Satisfaction With Smart Knee Implants
RECRUITING · NA
-
Medrol Dosepak for Outpatient Total Knee Arthroplasty
RECRUITING · Phase 4
-
Enhanced Recovery After Major Surgery and Chronic Pain for Total Knee Arthroplasty
RECRUITING · NA
-
Improving Rehabilitation for Veterans After Total Knee Arthroplasty Using Individualized Recovery Trajectories
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821623 · 118 participants · Phase 2
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
- NCT04040959 · 118 participants · Phase 2
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
- NCT04696029 · 118 participants · Phase 2
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- NCT05223192 · 118 participants · NA
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI